
Flemming Saether
Examiner (ID: 23, Phone: (571)272-7071 , Office: P/3677 )
| Most Active Art Unit | 3677 |
| Art Unit(s) | 3679, 3675, 3627, 3751, 3508, 3677, 2899 |
| Total Applications | 3720 |
| Issued Applications | 2542 |
| Pending Applications | 266 |
| Abandoned Applications | 947 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18242781
[patent_doc_number] => 20230075092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => COMBINATION OF DILTIAZEM AND VIRAL POLYMERASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/792403
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792403 | Combination of diltiazem and viral polymerase inhibitors | Jan 11, 2021 | Issued |
Array
(
[id] => 18230592
[patent_doc_number] => 20230069586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS OF USING ANDROGRAPHOLIDE, ORIDONIN AND ISOLIQUIRITIGENIN AND DERIVATIVES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/790594
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790594 | METHODS OF USING ANDROGRAPHOLIDE, ORIDONIN AND ISOLIQUIRITIGENIN AND DERIVATIVES THEREOF | Jan 7, 2021 | Pending |
Array
(
[id] => 17005300
[patent_doc_number] => 20210236461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => AGENT FOR ELIMINATING SENESCENT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/143689
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17143689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/143689 | Agent for eliminating senescent cells | Jan 6, 2021 | Issued |
Array
(
[id] => 18716479
[patent_doc_number] => 11793800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Methods and compositions to inhibit adverse effects associated with vaccinations
[patent_app_type] => utility
[patent_app_number] => 17/136799
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4600
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136799 | Methods and compositions to inhibit adverse effects associated with vaccinations | Dec 28, 2020 | Issued |
Array
(
[id] => 18427608
[patent_doc_number] => 11672807
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-13
[patent_title] => Oral testosterone non-undecanoate therapy
[patent_app_type] => utility
[patent_app_number] => 17/132167
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17669
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17132167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/132167 | Oral testosterone non-undecanoate therapy | Dec 22, 2020 | Issued |
Array
(
[id] => 18183255
[patent_doc_number] => 20230043985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => ONCE DAILY CANCER TREATMENT REGIMEN WITH A PRMT5 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/786695
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786695 | ONCE DAILY CANCER TREATMENT REGIMEN WITH A PRMT5 INHIBITOR | Dec 14, 2020 | Abandoned |
Array
(
[id] => 16990108
[patent_doc_number] => 20210228528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD FOR TREATING METASTATIC PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/120228
[patent_app_country] => US
[patent_app_date] => 2020-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17120228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/120228 | Method for treating metastatic prostate cancer | Dec 12, 2020 | Issued |
Array
(
[id] => 18368083
[patent_doc_number] => 11648230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Method for treating rheumatoid arthritis
[patent_app_type] => utility
[patent_app_number] => 17/120233
[patent_app_country] => US
[patent_app_date] => 2020-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5654
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17120233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/120233 | Method for treating rheumatoid arthritis | Dec 12, 2020 | Issued |
Array
(
[id] => 17020830
[patent_doc_number] => 20210244701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHOD FOR TREATING INFECTIOUS DISEASES WITH ISOTHIOCYANATE FUNCTIONAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/120219
[patent_app_country] => US
[patent_app_date] => 2020-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17120219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/120219 | Method for treating infectious diseases with isothiocyanate functional compounds | Dec 12, 2020 | Issued |
Array
(
[id] => 17124440
[patent_doc_number] => 20210299208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/949891
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16949891
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/949891 | SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION | Nov 18, 2020 | Abandoned |
Array
(
[id] => 16976078
[patent_doc_number] => 20210220315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => NITRATED-FATTY ACIDS MODULATION OF TYPE II DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/950805
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950805 | NITRATED-FATTY ACIDS MODULATION OF TYPE II DIABETES | Nov 16, 2020 | Abandoned |
Array
(
[id] => 16686677
[patent_doc_number] => 20210069152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => METHODS FOR TREATING HETEROTOPIC OSSIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/950604
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950604
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950604 | Methods for treating heterotopic ossification | Nov 16, 2020 | Issued |
Array
(
[id] => 16670525
[patent_doc_number] => 20210059288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AGING AND/OR IMPROVING HUMAN HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/096772
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096772 | Compositions and methods for treating aging and/or improving human health | Nov 11, 2020 | Issued |
Array
(
[id] => 20413025
[patent_doc_number] => 12496287
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Compositions and methods for treating macrophage activation syndrome
[patent_app_type] => utility
[patent_app_number] => 17/771172
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 33
[patent_no_of_words] => 2175
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771172
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771172 | Compositions and methods for treating macrophage activation syndrome | Nov 8, 2020 | Issued |
Array
(
[id] => 16776439
[patent_doc_number] => 20210113516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => PREVENTION AND TREATMENT OF VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/089020
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089020 | Prevention and treatment of viral infections | Nov 3, 2020 | Issued |
Array
(
[id] => 19490521
[patent_doc_number] => 12109205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Methods of treating Fabry patients having renal impairment
[patent_app_type] => utility
[patent_app_number] => 17/078840
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 19815
[patent_no_of_claims] => 97
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17078840
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/078840 | Methods of treating Fabry patients having renal impairment | Oct 22, 2020 | Issued |
Array
(
[id] => 18328173
[patent_doc_number] => 11633388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Methods of treating Fabry patients having renal impairment
[patent_app_type] => utility
[patent_app_number] => 17/078765
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 18868
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17078765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/078765 | Methods of treating Fabry patients having renal impairment | Oct 22, 2020 | Issued |
Array
(
[id] => 18353950
[patent_doc_number] => 11642334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Methods of treating Fabry patients having renal impairment
[patent_app_type] => utility
[patent_app_number] => 17/077397
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 19806
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077397
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077397 | Methods of treating Fabry patients having renal impairment | Oct 21, 2020 | Issued |
Array
(
[id] => 18273673
[patent_doc_number] => 11612594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Methods of treating Fabry patients having renal impairment
[patent_app_type] => utility
[patent_app_number] => 17/077389
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 19814
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077389
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077389 | Methods of treating Fabry patients having renal impairment | Oct 21, 2020 | Issued |
Array
(
[id] => 16686687
[patent_doc_number] => 20210069162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Methods Of Treating Fabry Patients Having Renal Impairment
[patent_app_type] => utility
[patent_app_number] => 17/077402
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077402 | Methods of treating Fabry patients having renal impairment | Oct 21, 2020 | Issued |